Teleperformance Named to PEOPLE’s Annual List of “100 Companies that Care” for 2022 Read more about Teleperformance Named to PEOPLE’s Annual List of “100 Companies that Care” for 2022
TECO 2030 signs supplier partnership agreement with SinoHyKey Read more about TECO 2030 signs supplier partnership agreement with SinoHyKey
Norsk Hydro: Annual report 2021 - European Single Electronic Format (ESEF) Read more about Norsk Hydro: Annual report 2021 - European Single Electronic Format (ESEF)
Press Release: Statement from Sanofi regarding Horizon Therapeutics plc (“Horizon”) Read more about Press Release: Statement from Sanofi regarding Horizon Therapeutics plc (“Horizon”)
MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting Read more about MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting
Satisfaction of the Final Conditions to the Transaction with Eagle Football Read more about Satisfaction of the Final Conditions to the Transaction with Eagle Football
MaaT Pharma Presents Compelling Consolidated MaaT013 Clinical Data at the 64th ASH Annual Meeting Read more about MaaT Pharma Presents Compelling Consolidated MaaT013 Clinical Data at the 64th ASH Annual Meeting
argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia Read more about argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Sézary Syndrome at ASH 2022 Read more about Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Sézary Syndrome at ASH 2022